May 1, 2024 Critical Path for Parkinson’s Celebrates Foundational 10-year Milestone Critical Path Institute’s Critical Path for Parkinson’s consortium is celebrating a significant 10-year milestone today. The g
April 23, 2024 Clinical Outcome Assessment — Initial Public Discussion In this presentation from C-Path's rare and orphan disease program, you will see...
May 15, 2024 TRxA BioBRIDGe Awards: Supporting the Next Generation of Protein-Based Therapeutics TRxA is proud to announce the 2024 global Request for Proposals for its Biologics-focused Bridging Research...
May 23, 2024 Webinar: The Use and Development of DHTs with Patient Advocacy Groups Join C-Path and Dr. Laurent Servais for an overview of Actimyo and relevant learnings...
April 24, 2024 COA Program Concludes Successful Annual Meeting On April 17 and 18, Critical Path Institute’s Clinical Outcome Assessment (COA) Program hosted its Annual Meeting in Rockville,
September 26, 2024-September 27, 2024 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) is delighted to announce the second...
September 9, 2024-September 12, 2024 Save the Date for C-Path’s Premier Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a
C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E
April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.